Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Leukemia, Myeloid, Acute 3Carcinoma, Merkel Cell 3Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Neoplasms 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Platinum-resistant Ovarian Cancer 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms, Glandular and Epithelial 1Neoplasms by Histologic Type 1Myelodysplastic Syndromes 1Multiple Myeloma 1Microsatellite Instability 1Melanoma 1Lymphoma, B-Cell 1Glioblastoma 1Castration Resistant Prostate Cancer 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Carcinoma 1Adenocarcinoma 1

Interventions

Gemcitabine 12Mitomycin 6Docetaxel 4Radiotherapy 3BCG Vaccine 3tislelizumab 2erdafitinib 2dodecyl maltoside 2disitamab vedotin 2toripalimab 1pemigatinib 1pembrolizumab 1monalizumab 1linrodostat 1enzalutamide 1durvalumab 1bicalutamide 1avelumab 1Sugars 1Postoperative Period 1Pentosan Sulfuric Polyester 1Nonsteroidal Anti-Androgens 1Nivolumab 1Metformin 1Imiquimod 1Hyaluronic Acid 1High-Intensity Interval Training 1Gels 1Epirubicin 1Cystoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Non-Muscle Invasive Bladder Neoplasms × ALT-803 × Clear all
NCT06829823 2025-10-16

Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

ImmunityBio, Inc.

Phase 2 Not yet recruiting
20 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡